LB PHARMACEUTICALS INC (LBRX:NASDAQ)
$40.08 -0.82 (-2.0049%)
Analysed LB PHARMACEUTICALS INC (LBRX:NASDAQ) News Sources
LB Pharmaceuticals (NASDAQ:LBRX) Is In A Good Position To Deliver On Growth Plans
14-05-2026
yahoo.com
All You Need to Know About LB Pharmaceuticals Inc (LBRX) Rating Upgrade to Buy
26-05-2026
yahoo.com
LB Pharmaceuticals to Participate in Upcoming June Investor Events
28-05-2026
yahoo.com
Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles
08-06-2026
fool.com
LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations
30-06-2026
yahoo.com
LB Pharmaceuticals Inc. (LBRX) Maintains Buy Rating as Analyst Highlights LB-102 Potential
02-07-2026
yahoo.com
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
10-07-2026
yahoo.com
Shopify downgraded, Five Below upgraded: Wall Street's top analyst calls
21-07-2026
yahoo.com
LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia
22-07-2026
yahoo.com
LB Pharmaceuticals Announces $150 Million Private Placement
29-07-2026
yahoo.com
What is the current price of LB PHARMACEUTICALS INC (LBRX:NASDAQ)?
The current price of LB PHARMACEUTICALS INC (LBRX:NASDAQ) is $40.08.
LB PHARMACEUTICALS INC (LBRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of LB PHARMACEUTICALS INC (LBRX:NASDAQ) since the previous trading day is $-0.82.
LB PHARMACEUTICALS INC (LBRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of LB PHARMACEUTICALS INC (LBRX:NASDAQ) since the previous trading day is -2.0049%.
What is the most recent average sentiment score for LB PHARMACEUTICALS INC (LBRX:NASDAQ)?
The most recent average sentiment score for LB PHARMACEUTICALS INC (LBRX:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for LB PHARMACEUTICALS INC (LBRX:NASDAQ)?
The most recent sentiment for LB PHARMACEUTICALS INC (LBRX:NASDAQ) is .
SEC-8K** Filing Available For LB PHARMACEUTICALS INC (LBRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.